Cantor Fitzgerald Reiterates Overweight Rating on Tenax Therapeutics, Inc. (TENX)
Rating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Tenax Therapeutics, Inc. (NASDAQ:TENX) on June 24, 2026. Market Context Tenax Therapeutics, Inc.
Read more
